This partnership with IMPAC will afford Siemens customers access to IMPAC’s latest innovative oncology information system (OIS) in addition to the radiation therapy systems from Siemens.
Moreover, Siemens and IMPAC will work together to develop interfaces between MOSAIQ and IONTRIS, making it possible to use MOSAIQ with Siemens particle therapy solutions in the future. Under the extended agreement, Siemens will offer the MOSAIQ software as its next generation OIS offering to LANTIS, the OIS currently sold by Siemens. Siemens LANTIS customers will have the option of upgrading to MOSAIQ or continuing to utilize their LANTIS systems. Siemens will extend service support and application training for its customers to include MOSAIQ.
MOSAIQ is an image-enabled electronic medical record for oncology that allows documentation of patient data, from diagnosis to therapy. Clinical images, lab results, and external documents can also be integrated. Support for additional business functions such as scheduling, invoicing, management reporting and analysis, among others, can also be implemented. "We have maintained a very successful partnership with IMPAC since 1992 in the area of oncology information systems. In addition to cooperating on the development of interfaces for our systems for photon and electron radiation therapy, we are now working together in particle therapy. We are confident we will be able to offer our customers sustainable oncology systems which help them to optimize workflows and master the daily challenges of the hospital routine," said Holger Schmidt, CEO Oncology Care Systems, Siemens Healthcare.
"We are pleased to partner with Siemens and look forward to continuing a long and mutually beneficial relationship. We are certain MOSAIQ will assist clinicians to efficiently manage even the most demanding workflows in oncology enabling our customers to deliver the best possible patient care," said Jay Hoey, IMPAC President and CEO.
About IMPAC Medical Systems, Inc. IMPAC Medical Systems, Inc., part of the Elekta Group, provides software solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC’s open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as systems for anatomic pathology, clinical laboratory and cancer registry. With products that cover diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency and quality patient care. The Elekta Group provides oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight cancer and brain disorders. With more than 2,500 employees globally, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros.
Virtual Reality in Medicine: New Opportunities for Diagnostics and Surgical Planning
07.12.2016 | Universität Basel
3-D printed kidney phantoms aid nuclear medicine dosing calibration
06.12.2016 | Society of Nuclear Medicine
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences